: Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’

‘We need vaccines with longer duration and greater breadth of protection,’ said Dr. David Kessler, chief science officer for the White House’s COVID-19 response team.